Shares of Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) gapped down before the market opened on Thursday. The stock had previously closed at $2.5075, but opened at $2.40. Raia Drogasil shares last traded at $2.40, with a volume of 1,050 shares changing hands.
Analyst Ratings Changes
Separately, Jefferies Financial Group upgraded shares of Raia Drogasil to a “buy” rating and set a $5.20 price objective for the company in a research report on Sunday, October 18th. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, Raia Drogasil currently has a consensus rating of “Moderate Buy” and an average price target of $5.20.
Get Our Latest Analysis on Raia Drogasil
Raia Drogasil Stock Down 3.7%
Raia Drogasil (OTCMKTS:RADLY – Get Free Report) last posted its earnings results on Tuesday, November 3rd. The company reported $0.05 EPS for the quarter, meeting analysts’ consensus estimates of $0.05. Raia Drogasil had a return on equity of 20.61% and a net margin of 2.89%. The company had revenue of $2.22 billion for the quarter, compared to the consensus estimate of $2.43 billion. As a group, equities analysts predict that Raia Drogasil S.A. will post 0.17 earnings per share for the current year.
About Raia Drogasil
Raia Drogasil, now known as RD Saúde, is a Brazilian health and pharmacy retail company formed in 2011 through the merger of Droga Raia and Drogasil. It operates pharmacy stores under the Raia and Drogasil brands. The company sells prescription and over-the-counter medicines, personal care and beauty products, and other health and wellness goods. It serves customers across Brazil through its retail locations and digital channels, including online ordering and delivery. In addition to pharmacy retail, RD Saúde provides health-related services through its stores and digital platforms.
Further Reading
- Five stocks we like better than Raia Drogasil
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
- 3 Niche ETFs Are Beating the S&P 500, and Their Strategies Are Anything but Typical
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
